NCT00655083 - A Phase I Study to Evaluate the Oral Absorption of Nepadutant in Infants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions

Infantile ColicInfantile Functional Gastrointestinal Disorders

Interventions

DRUG

Nepadutant

0.1 mg/Kg as one single oral dose divided in three age strata (from 6 to 24 weeks old)

DRUG

Nepadutant

0.5 mg/Kg as one single oral dose divided in three age strata (from 6 to 24 weeks old)

Trial Locations (3)

Kosair Charities Pediatric Clinical Rsearch Unit University of Louisville, Louisville

Rainbow Babies and Children's Hospital, Cleveland

Arkansas Children's Hospital, Little Rock